Healthcare Mar 01, 2022 09:12 AM (GMT+8) · EqualOcean
According to the disclosure of the Hong Kong stock exchange, China Digital chronic disease management platform Zhiyun health technology group submitted an updated prospectus to the Hong Kong Stock Exchange on February 28, 2022. According to its preliminary financial data in 2021, the company's revenue in 2021 was 1.75 billion, with an annual growth rate of 109%, which is the highest growth rate among internet medical companies. In 2021, the gross profit was 570 million, with a gross profit margin of 32.4%, significantly higher than that of the same period last year. At the same time, the adjusted net loss also narrowed rapidly. Zhiyun health is the largest chronic disease management platform in China and the largest SaaS provider of chronic disease management in China. With technical advantages, Zhiyun health connects hospitals, doctors, pharmacies, pharmaceutical manufacturers and patients with hospital SAAS and pharmacy SaaS, opens up the whole scene of chronic disease management, and provides three solutions to cover the whole life cycle of chronic disease management from inside to outside the hospital, leading the digitization of China's chronic disease management market.

This text is a result of machine translation.